148results about How to "Suitable property" patented technology

A method of fabricating hafnium oxide and/or zirconium oxide films is provided. The methods include providing a mixture of Hf and/or Zr alkoxide dissolved, emulsified or suspended in a liquid; vaporizing at least the alkoxide and depositing the vaporized component at a temperature of greater than 400° C. The resultant film is dense, microcrystalline and is capable of self-passivation when treated in a hydrogen plasma or forming gas anneal.

The capability of retaining a resistance value of a stored state and an erased state is improved in a resistance variation-type memory device. A memory layer 5 including a high-resistance layer 2 and an ion source layer 3 is provided between a lower electrode 1 and an upper electrode 4. The ion source layer 3 contains Al (aluminum) as an additive element together with an ion conductive material such as S (sulfur), Se (selenium), and Te (tellurium) (chalcogenide element) and a metal element to be ionized such as Zr (zirconium). Since Al is included in the ion source layer 3, the high-resistance layer which includes Al (Al oxide) is formed on an anode in erasing operation. Thus, a retaining property in a high-resistance state improves, and at the same time, an operating speed is improved.

The present invention relates to pharmaceutical compositions in particulate form or in solid dosage forms comprising a combination of fenofibrate and the HMG CoA reductase inhibitor rosuvastatin or a pharmaceutically active salt thereof, which upon oral administration provides a relative AUC_0-24 value (AUC_{fibric acid}/AUC_rosuvastatin) of between about 150 and about 12,000. The solid compositions are manufactured without any need of addition of water or aqueous medium and comprise at least 80% of the active substances fenofibrate and rosuvastatin in dissolved form, or, optionally, atorvastatin in micronized form, in order to ensure suitable bioavailability.

In all of an in-plane magnetic recording system and a perpendicular magnetic recording system, there is provided a crystallized glass for a disk substrate for information recording medium, etc., which has satisfactory surface properties capable of sufficiently adapting with a lamp loading system for high-density recording, has high strength such that it is able to withstand high-speed rotation and impact, has heat expansion properties and heat resistance in agreement with respective drive members, has a low melting temperature, has excellent productivity and is reduced in the elution amount of an alkali from the raw material, namely excellent in chemical durability. The crystallized glass of the invention is a crystallized glass containing an SiO₂ component and an Li₂O component; further containing at least one member selected from an SrO component and a BaO component in a total content of more than 3.5% and not more than 15% in terms of % by mass; and containing at least one member selected among lithium disilicate, lithium monosilicate, α-quartz, an α-quartz solid solution and a β-quartz solid solution as a main crystal phase on the oxide basis.

Processable rubber compositions contain a vulcanized fluorocarbon elastomer dispersed in a thermoplastic matrix comprising a fully fluorinated polymer and a partially fluorinated polymer. The processing temperature is below the melting point of the fully fluorinated polymer. The compositions are made by combining a curative, uncured fluorocarbon elastomer, a fully fluorinated thermoplastic, and a partially fluorinated thermoplastic material, and heating the mixture at a temperature and for a time sufficient to effect vulcanization of the elastomeric material, while mechanical energy is applied to mix the mixture during the heating step. Shaped articles such as seals, gaskets, O-rings, and hoses may be readily formed from the rubber compositions according to conventional thermoplastic processes such as blow molding, injection molding, and extrusion.

The present invention is a laminating process which is directed toward economical production methods for scalable amounts of production which develop properties suitable for a broad based product line. In particular, the product is capable of important key components of commercial properties such as adhesion, scratch resistance, chemical inertness, and bending without failure.

A process involves adding a peroxide masterbatch to a molten blend of a fluorocarbon elastomer and a thermoplastic material. The peroxide masterbatch contains greater than or equal to 5% weight percent organic peroxide, further contains a fluorocarbon elastomer, and typically also contains a crosslinker containing at least two sites of olefinic unsaturation. The fluorocarbon elastomer in the molten blend and in the peroxide masterbatch may be the same or different. After the peroxide masterbatch is added to the molten blend, the combination is mixed at a temperature and for a time sufficient to effect cure of the fluorocarbon elastomers. By using a masterbatch, a faster and more uniform dispersion of peroxide curative is possible due to pre-dispersion of peroxide in the elastomer phase, which leads to shaped articles having improved mechanical properties.

Disclosed is a field-effect transistor characterized by using a compound represented by the formula (1) below as a semiconductor material.

(In the formula (1), X¹ and X² independently represent a sulfur atom, a selenium atom or a tellurium atom; and R¹ and R² independently represent an unsubstituted or halogeno-substituted C₁-C₃₆ aliphatic hydrocarbon group.)

A compound has the following formula:

The compound is a p38 MAP kinase inhibitor. The compound and its pharmaceutically acceptable salts can be used for treatment of conditions, such as inflammatory diseases.

A ceramic sheet 20 is produced by a method in which inorganic particles including, as a main component, an oxide represented by general formula ABO₃ and containing a volatile component are mixed such that the A/B ratio is 1.05 or more, the inorganic particles are formed into a self-supported planar shaped body with a thickness of 30 μm or less, and the shaped body is fired, without an inactive layer or with an inactive layer which does not substantially react with the shaped body and is disposed adjacent to the shaped body, at a temperature-rising rate of 30° C./min or more in a temperature range which is equal to or higher than a temperature at which the volatile component is volatilized.

The present invention pertains to a sized product, which contains a drug, polyethylene oxide with a molecular weight of 2,000,000 or higher, and a specific size controlling agent for polyethylene oxide (substance with the appropriate plasticity and binding force) and wherein at least the above-mentioned specific size controlling agent is uniformly dispersed in the above-mentioned polyethylene oxide, a controlled-release pharmaceutical composition containing this sized product, and a method of manufacturing a controlled-release pharmaceutical composition containing this sized product.

A controlled-release pharmaceutical composition with good uniformity of content can be presented by using powder particles of polyethtylene oxide with powder properties suitable for tableting, which is obtained by uniform dispersion of the specific size controlling agent for polyethylene oxide of the present invention.